Literature DB >> 14643661

Comparison of the structure and DNA-binding properties of the E2 proteins from an oncogenic and a non-oncogenic human papillomavirus.

Ghislaine Dell1, Kay W Wilkinson, Rebecca Tranter, Joanna Parish, R Leo Brady, Kevin Gaston.   

Abstract

Human papillomaviruses (HPVS) that infect the genital tract can be divided into two groups: high-risk HPV types, such as HPV 16 and HPV 18, are associated with cancer, low-risk HPV types, such as HPV 6, are associated with benign warts. In both high-risk and low-risk HPV types, the papillomavirus E2 protein binds to four sites within the viral long control region (LCR) and regulates viral gene expression. Here, we present the crystal structure of the minimal DNA-binding domain (DBD) from the HPV 6 E2 protein. We show that the HPV 6 E2 DBD is structurally more similar to the HPV 18 and bovine papillomavirus type 1 (BPV1) E2 proteins than it is to the HPV 16 E2 protein. Using gel retardation assays, we show that the hierarchy of E2 sites within the HPV 16 and HPV 6 LCRs are different. However, despite these differences in structure and site preference, both the HPV 16 and 6 E2 DBDs recognise an extended version of the consensus E2 binding site derived from studies of the BPV1 E2 protein. In both cases, the preferred binding site is 5'AACCGN(4)CGGTT3', where the additional flanking base-pairs are in bold and N(4) represents a four base-pair central spacer. Both of these HPV proteins bind preferentially to E2 sites that contain an A:T-rich central spacer. We show that the preference for an A:T-rich central spacer is due, at least in part, to the need to adopt a DNA conformation that facilitates protein contacts with the flanking base-pairs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14643661     DOI: 10.1016/j.jmb.2003.10.009

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  15 in total

1.  Solution structure of the HPV-16 E2 DNA binding domain, a transcriptional regulator with a dimeric beta-barrel fold.

Authors:  Alejandro D Nadra; Tommaso Eliseo; Yu-Keung Mok; C L Almeida; Mark Bycroft; Maurizio Paci; Gonzalo de Prat-Gay; Daniel O Cicero
Journal:  J Biomol NMR       Date:  2004-10       Impact factor: 2.835

2.  E2 proteins from high- and low-risk human papillomavirus types differ in their ability to bind p53 and induce apoptotic cell death.

Authors:  Joanna L Parish; Anna Kowalczyk; Hsin-Tien Chen; Geraldine E Roeder; Richard Sessions; Malcolm Buckle; Kevin Gaston
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

3.  Design and characterization of an enhanced repressor of human papillomavirus E2 protein.

Authors:  Kakoli Bose; Gretchen Meinke; Andrew Bohm; James D Baleja
Journal:  FASEB J       Date:  2011-04-11       Impact factor: 5.191

4.  Identification and analysis of papillomavirus E2 protein binding sites in the human genome.

Authors:  Liisi Võsa; Aleksander Sudakov; Maido Remm; Mart Ustav; Reet Kurg
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

5.  Protein flexibility directs DNA recognition by the papillomavirus E2 proteins.

Authors:  Craig Brown; Karen Campos-León; Madeleine Strickland; Christopher Williams; Victoria Fairweather; R Leo Brady; Matthew P Crump; Kevin Gaston
Journal:  Nucleic Acids Res       Date:  2010-12-03       Impact factor: 16.971

6.  Evolutionary variation of papillomavirus E2 protein and E2 binding sites.

Authors:  Adam Rogers; Mackenzie Waltke; Peter C Angeletti
Journal:  Virol J       Date:  2011-08-01       Impact factor: 4.099

7.  The recognition of local DNA conformation by the human papillomavirus type 6 E2 protein.

Authors:  Elizabeth Hooley; Victoria Fairweather; Anthony R Clarke; Kevin Gaston; R Leo Brady
Journal:  Nucleic Acids Res       Date:  2006-08-12       Impact factor: 16.971

Review 8.  Targeting mitotic chromosomes: a conserved mechanism to ensure viral genome persistence.

Authors:  Katherine M Feeney; Joanna L Parish
Journal:  Proc Biol Sci       Date:  2009-01-20       Impact factor: 5.349

9.  Human papillomavirus type 16 E2 protein transcriptionally activates the promoter of a key cellular splicing factor, SF2/ASF.

Authors:  Sarah Mole; Steven G Milligan; Sheila V Graham
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

Review 10.  Evolutionary and biophysical relationships among the papillomavirus E2 proteins.

Authors:  Dukagjin M Blakaj; Narcis Fernandez-Fuentes; Zigui Chen; Rashmi Hegde; Andras Fiser; Robert D Burk; Michael Brenowitz
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.